| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.22 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.41 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.5 |